(Q70730461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Potentiation of EO9 anti-tumour activity by hydralazine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

M C Bibby

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

N R Sleigh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

J A Double

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

29A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

1033-1035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

Potential bioreductive alkylating agents. 1. Benzoquinone derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

Effects of Two Tumour Blood Flow Modifiers, Hydralazine and Flavone Acetic Acid, on KHT Tumours and Normal Tissues in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980218-7

7 January 2021

10.1016/S0959-8049(05)80218-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8499134%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference